Recombinant Ret Proto-Oncogene (RET)

• Product Name Alternative:

  CDHR16; CRet; PTC; CDHF12; HSCR1; MEN2A; MEN2B; MTC1; RET-ELE1; RET51; C-Ret; Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1; Cadherin-Related 16

• Synonyms:

  Ret Proto-Oncogene

• UniProt:

  P07949

• Expression System:

  Prokaryotic expression

• Host:

  E. coli

• Tag:

  N-terminal His Tag

• Source:

  Prokaryotic expression

• Applications:

  Positive Control; Immunogen; SDS-PAGE; WB.

• Field of Research:

  CD & Adhesion molecule, Tumor immunity, Hormone metabolism

• Endotoxin:

  < 1.0 EU per 1 µg (determined by the LAL method)

• Purity:

  > 90%

• Form:

  Freeze-Dried Powder

• Buffer:

  PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

• Calculated Molecular Weight:

  26.3 KDa

• Observed Molecular Weight:

  26kDa

• Fragment:

  Thr78~Phe272

• Isoelectric Point:

  6.1

• Subcellular Location:

  Membrane

• Organism Species:

  Homo sapiens (Human)

• CAS Number:

  9000-83-3